Literature DB >> 35585442

Antimicrobial resistance among Haemophilus influenzae isolates responsible for lower respiratory tract infections in Poland, 2005-2019.

Marlena Kiedrowska1, Weronika Jasmina Foryś2, Agnieszka Gołębiewska3, Izabela Waśko3,4, Patrycja Ronkiewicz3, Alicja Kuch3, Izabela Wróbel-Pawelczyk3, Michał Wroczyński3,5, Waleria Hryniewicz3, Anna Skoczyńska3.   

Abstract

Haemophilus influenzae is a human-specific pathogen responsible for respiratory tract infections, meningitis, and sepsis. The study aimed to characterize antibiotic resistance in H. influenzae strains isolated from patients with lower respiratory tract infections over 15 years in Poland. The minimum inhibitory concentrations (MICs) of clinically relevant antibiotics were determined by broth microdilution method. Screening for beta-lactam resistance was performed in all isolates following EUCAST recommendation. Finally, relevant changes in penicillin-binding protein 3 (PBP3) were detected by PCR screening. Of the 1481 isolates collected between 2005 and 2019, 12.6%, 0.2%, 17.1%, and 0.2% were resistant to ampicillin, amoxicillin/clavulanate, cefuroxime, and ceftriaxone, respectively. Among them, 74.4% (1102/1481) of isolates were categorized as BLNAS (β-lactamase negative, ampicillin-susceptible), 13.0% (192/1481) as BLNAS with modified PBP3 (mutations in ftsI gene), 2.6% (39/1481) as BLNAR (β-lactamase negative, ampicillin-resistant), and 0.2% had PBP3 modifications typical for high-BLNAR. Production of β-lactamase characterized 9.7% of isolates (8.6% BLPAR-β-lactamase-positive, ampicillin-resistant, and 1.1% BLPACR-β-lactamase-positive, amoxicillin-clavulanate resistant). Three isolates with PBP3 modifications typical for high-BLNAR proved resistant to ceftriaxone (MIC > 0.125 mg/L). Resistance to ciprofloxacin, chloramphenicol, tetracycline, and trimethoprim-sulfamethoxazole was observed in 0.1%, 0.5%, 1.6%, and 24.7% of isolates, respectively. This is the first report of Polish H. influenzae isolates resistant to third-generation cephalosporins. Polish H. influenzae isolates demonstrate similar susceptibility trends as in many other countries. The substantial proportion of β-lactam-resistant isolates and the emergence of those resistant to third-generation cephalosporins are of great concern and should be under surveillance.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  BLNAR; BLPACR; BLPAR; Haemophilus influenzae; Resistance; Susceptibility

Mesh:

Substances:

Year:  2022        PMID: 35585442     DOI: 10.1007/s10096-022-04457-w

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  35 in total

1.  Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.

Authors:  K Ubukata; Y Shibasaki; K Yamamoto; N Chiba; K Hasegawa; Y Takeuchi; K Sunakawa; M Inoue; M Konno
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance.

Authors:  Maria Giufrè; Rita Cardines; Maria Grazia Caporali; Marisa Accogli; Fortunato D'Ancona; Marina Cerquetti
Journal:  Vaccine       Date:  2011-04-01       Impact factor: 3.641

3.  The changing epidemiology of invasive Haemophilus influenzae disease: Emergence and global presence of serotype a strains that may require a new vaccine for control.

Authors:  Raymond S W Tsang; Marina Ulanova
Journal:  Vaccine       Date:  2017-06-27       Impact factor: 3.641

4.  Antibiotic susceptibility and molecular analysis of invasive Haemophilus influenzae in Canada, 2007 to 2014.

Authors:  Raymond S W Tsang; Michelle Shuel; Kathleen Whyte; Linda Hoang; Gregory Tyrrell; Greg Horsman; John Wylie; Frances Jamieson; Brigitte Lefebvre; David Haldane; Rita R Gad; Gregory J German; Robert Needle
Journal:  J Antimicrob Chemother       Date:  2017-05-01       Impact factor: 5.790

5.  Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae.

Authors:  S M Markowitz
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

6.  Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin.

Authors:  A A Medeiros; T F O'Brien
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

7.  Carriage of Haemophilus influenzae in the oropharynx of young children and molecular epidemiology of the isolates after fifteen years of H. influenzae type b vaccination in Italy.

Authors:  Maria Giufrè; Laura Daprai; Rita Cardines; Paola Bernaschi; Lucilla Ravà; Marisa Accogli; Massimiliano Raponi; Maria Laura Garlaschi; Marta Luisa Ciofi degli Atti; Marina Cerquetti
Journal:  Vaccine       Date:  2015-10-09       Impact factor: 3.641

8.  Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012-2016.

Authors:  Maria Giufrè; Massimo Fabiani; Rita Cardines; Flavia Riccardo; Maria Grazia Caporali; Fortunato D'Ancona; Patrizio Pezzotti; Marina Cerquetti
Journal:  Vaccine       Date:  2018-10-03       Impact factor: 3.641

Review 9.  Antimicrobial resistance in Haemophilus influenzae.

Authors:  Stephen Tristram; Michael R Jacobs; Peter C Appelbaum
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

10.  Extensively drug-resistant Haemophilus influenzae - emergence, epidemiology, risk factors, and regimen.

Authors:  Pei-Yi Su; Ay-Huey Huang; Chung-Hsu Lai; Hsiu-Fang Lin; Tsun-Mei Lin; Cheng-Hsun Ho
Journal:  BMC Microbiol       Date:  2020-04-28       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.